Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | Methyl 3-bromobenzoate | HCID 12070 | — |
| Reactant | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| Reactant | 4,4-Difluoropiperidine hydrochloride | HCID 2758351 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 86690970 | HCID 86690970 | — |
Reaction Steps
In a microwave reaction vessel, a solution of 500 mg (2.33 mmol) of methyl 3-bromobenzoate and 366 mg (2.33 mmol) of 4,4-difluoropiperidine hydrochloride in 15 ml of dioxane was deoxygenated by passing through argon. 52 mg (0.233 mmol) of palladium(II) acetate, 202 mg (0.349 mmol) of 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (xantphos) and 2.27 g (6.98 mmol) of caesium carbonate were then added. The microwave vessel was closed with a crimp closure and, with magnetic stirring, heated in a microwave oven (Biotage Initiator, with Dynamic Field Tuning) at 120-140° C. for 1.5 hours. After the reaction had ended the reaction mixture was filtered through a little kieselguhr and then evaporated to dryness. The residue was separated into its components by preparative HPLC (Method 33). Evaporation of the product fractions and drying of the residue under high vacuum gave 342 mg (57% of theory) of the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09394309B2 |
|---|
| Source dataset | uspto-grants-2016_07 |
|---|
| ORD ID | ord-cfdda3d0003446b8863a505fb26a9bfa |
|---|
| Source note | uspto-grants-2016_07 |
|---|